In the lead up to the inaugural launch of Connect In Pharma, co-founder Wilfried Phipps provides insight into what visitors can expect at this new annual event designed to help shape the future of pharmaceutical packaging and manufacturing projects
31 August, 2022
Togo receives an outstanding achievement award as the first ever country to eliminate four neglected tropical diseases (NTDs) at the 72nd session of the WHO Regional Committee for Africa
24 August, 2022
Reading, 12 August 2022. Sanofi (EURONEXT: SAN and NASDAQ: SNY) and the National Institute for Health and Care Research (NIHR) have today announced that the first patient has been enrolled in the Hospitalised RSV Monoclonal Antibody Prevention (HARMONIE) study. The large European interventional clinical study is investigating protection against Respiratory syncytial virus (RSV) in infants. HARMONIE is an open label trial that will evaluate the use of nirsevimab, a passive immunisation, in a broad population. RSV is the leading cause of hospitalisation in all infants worldwide and affects 90% of children before the age of two.
18 August, 2022
The topic of this month’s newsletter from Drug Discovery Today is “Medicinal Chemistry”.
15 August, 2022
The newly announced agenda for Connect in Pharma focuses on innovation as the foundation of a strong pharmaceutical industry in Europe
09 August, 2022